Percutaneous coronary interventions have been performed for 20 years.
Despite the success and progress of these interventions, abrupt vessel
closure has been a dramatic adverse event of coronary interventions.
Closure has frequently led to the major complications of death, myocar
dial infarction, and emergency coronary artery bypass. Because of the
fear of this adverse event and its subsequent complications, the appli
cability of coronary interventions is sometimes limited. The pathologi
c characteristics of abrupt vessel closure have been recognized as pre
dominantly caused by dissection, with vessel recoil and thrombus forma
tion playing important secondary roles. The recognition of the lesions
at risk for abrupt vessel closure has led to a strategy of lesion-spe
cific device therapy to reduce complications. Similarly the role of an
tiplatelet and antithrombotic therapies have reduced complications. Th
e earliest methods of dealing with abrupt closure was emergency corona
ry artery bypass surgery with significant rates of morbidity and morta
lity. With the advent of second-generation devices and techniques, par
ticularly stents, the management of abrupt vessel closure has been sim
plified and alternatives to emergency coronary bypass are more availab
le. This article will review the history and current status of the pre
vention and management of abrupt vessel closure and demonstrate that a
nticipation and management of this complication have been facilitated
with reduction of subsequent complications and increased applicability
of coronary interventions.